SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer

Clinical trial NCT01086254 · COMPLETED

Trial details

NCT number: NCT01086254
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer Stage IV

Start date: 2010-05-01
Primary completion: 2011-12-01
Enrollment: 119

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.